Tuberculous meningitis
Tuberculous meningitis is the most serious type of extrapulmonary tuberculosis and the main cause of death from tuberculosis in children. It often occurs within one year of initial tuberculosis infection, especially within 3 to 6 months of initial tuberculosis infection. Due to the widespread vaccination of BCG and the development of tuberculosis prevention and control, its incidence has been significantly reduced. However, due to the unbalanced development of prevention and control work, this disease is still common in some areas, and most of the patients found are still in the late stage. Therefore, it is of great significance to understand the law of its occurrence and development, early diagnosis and reasonable treatment to reduce mortality and sequelae.
Related Drugs
Ethambutol Hydrochloride Tablets
Indication: It is suitable for the treatment of pulmonary tuberculosis caused by Mycobacterium tuberculosis in combination with other anti-tuberculosis drugs. It can also be used to treat tuberculous meningitis and atypical mycobacterial infections.
Manufacturer:
Jiangxi Pharmaceutical Co., Ltd.
Sodium p-aminosalicylate for injection
Indication: It is suitable for pulmonary and extrapulmonary tuberculosis caused by Mycobacterium tuberculosis. Intravenous infusion can be used to treat tuberculous meningitis and acute disseminated tuberculosis. This product is only effective against mycobacteria. When used alone, Mycobacterium tuberculosis can quickly develop drug resistance, so this product must be used in combination with other anti-tuberculosis drugs. When streptomycin and isoniazid are used in combination with this product, it can delay the development of drug resistance of Mycobacterium tuberculosis to the former two. This product is ineffective against atypical mycobacteria. It is mainly used as a second-line anti-tuberculosis drug.
Manufacturer:
Liaoning PHARMA-UNION Pharmaceutical Co., Ltd.
Calcium para-aminosalicylate tablets
Indication: 1. It is suitable for pulmonary and extrapulmonary tuberculosis caused by Mycobacterium tuberculosis. Intravenous drip can be used to treat tuberculous meningitis and acute hematogenous disseminated tuberculosis. 2. It can also be used for hyperthyroidism. For patients with hyperthyroidism and tuberculosis, it can be taken for a short period of time when iodine is ineffective and may affect surgery.
Manufacturer:
China Resources Double-Crane Pharmaceutical Co., Ltd.
Sodium p-aminosalicylate for injection
Indication: It is suitable for pulmonary and extrapulmonary tuberculosis caused by Mycobacterium tuberculosis. Intravenous infusion can be used to treat tuberculous meningitis and acute disseminated tuberculosis. This product is only effective against mycobacteria. When used alone, Mycobacterium tuberculosis can quickly develop drug resistance, so this product must be used in combination with other anti-tuberculosis drugs. When streptomycin and isoniazid are used in combination with this product, it can delay the development of drug resistance of Mycobacterium tuberculosis to the former two. This product is ineffective against atypical mycobacteria. It is mainly used as a second-line anti-tuberculosis drug.
Manufacturer:
Liaoning PHARMA-UNION Pharmaceutical Co., Ltd.
Fluorescein Sodium Injection
Indication: It is used for diagnosis of corneal injury, ulcer and foreign body, fundus angiography and circulation time measurement. It is also used for intraoperative display of gallbladder and bile duct, and auxiliary diagnosis of tuberculous meningitis.
Manufacturer:
Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd.
Fluorescein Sodium Injection
Indication: Diagnostic medicine. It is used for diagnosing corneal injuries, ulcers and foreign bodies, fundus angiography and circulation time measurement. It is also used for displaying gallbladder and bile duct during surgery, and for auxiliary diagnosis of tuberculous meningitis.
Rifampin
Indication: This product is used in combination with other anti-tuberculosis drugs for the initial and retreatment treatment of various tuberculosis, including the treatment of tuberculous meningitis.
Manufacturer:
Zhengzhou Minzhong Pharmaceutical Co., Ltd.
Rifampin
Indication: This product is used in combination with other anti-tuberculosis drugs for the initial and retreatment treatment of various tuberculosis, including the treatment of tuberculous meningitis.
Manufacturer:
Chengdu Jinhua Pharmaceutical Co., Ltd.
Rifampin
Indication: This product is used in combination with other anti-tuberculosis drugs for the initial and retreatment treatment of various tuberculosis, including the treatment of tuberculous meningitis.
Manufacturer:
Taishan City Xinning Pharmaceutical Co., Ltd.
Rifampin
Indication: This product is used in combination with other anti-tuberculosis drugs for the initial and retreatment treatment of various tuberculosis, including the treatment of tuberculous meningitis.
Manufacturer:
Hebei Xingang Pharmaceutical Co., Ltd.